Drug Profile
Milk allergy immunotherapy companion diagnostic - DBV Technologies
Alternative Names: DiallertestLatest Information Update: 28 Dec 2017
Price :
$50
*
At a glance
- Originator DBV Technologies
- Class Protein diagnostics
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Milk hypersensitivity
Most Recent Events
- 28 Dec 2017 No recent reports of development identified for clinical-Phase-Unknown development in Milk-hypersensitivity(Diagnosis, In adolescents, In children) in Canada (Topical, Patch)
- 20 Nov 2014 Clinical trials in Milk hypersensitivity (In adolescents, In children, Diagnosis) in Canada (Topical)